Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ECE1 | P42892 | 3/20 | 0.37 |
| ▸ | BHMT | Q93088 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.35 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.35 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.35 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.35 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.35 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.35 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.35 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10824295 | 1.00 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2SLC1A1ALOX15 | |
| SCHEMBL31206809 | 1.00 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2SLC1A1ALOX15 | |
| SCHEMBL5319867 | 1.00 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2SLC1A1ALOX15 | |
| SCHEMBL75174 | 0.83 | SLC7A5 (0.52) | SLC7A5SLC1A3SLC1A2SLC1A1KMT2A | |
| SCHEMBL2263294 | 0.83 | SLC7A5 (0.52) | SLC7A5SLC1A3SLC1A2SLC1A1KMT2A | |
| SCHEMBL497652 | 0.83 | SLC7A5 (0.52) | SLC7A5SLC1A3SLC1A2SLC1A1KMT2A | |
| SCHEMBL12648478 | 0.83 | SLC7A5 (0.52) | SLC7A5SLC1A3SLC1A2SLC1A1KMT2A | |
| SCHEMBL398726 | 0.83 | SLC7A5 (0.52) | SLC7A5SLC1A3SLC1A2SLC1A1KMT2A | |
| SCHEMBL4631190 | 0.81 | SLC7A5 (0.50) | SLC7A5SLC1A3SLC1A2SLC1A1BHMT | |
| Isoleucine SCHEMBL3194053 | 0.80 | SLC1A3 (0.46) | SLC7A5SLC1A3SLC1A2SLC1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2026-02-17 | — | — | US | claimed |
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Universität Zürich (CH) | 2024-08-29 | — | — | US | claimed |
| EP-4295866-A2 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Virometix AG (CH) | 2023-12-27 | — | — | EP | claimed |
| EP-3638284-B1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIROMETIX AG (CH) | 2023-08-30 | — | — | EP | claimed |
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2023-06-20 | — | — | US | claimed |
| US-20210101941-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Universität Zürich (CH) | 2021-04-08 | — | — | US | claimed |
| EP-3638284-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Virometix AG (CH) | 2020-04-22 | — | — | EP | claimed |
| CN-110891592-A | Cyclic peptides for protection against respiratory syncytial virus | 维罗米蒂克斯股份公司 | 2020-03-17 | — | — | CN | claimed |
| WO-2018229156-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIROMETIX AG (CH) | 2018-12-20 | — | — | WO | claimed |
| US-20260137767-A1 | LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES | VIROMETIX AG (CH) | 2026-05-21 | — | — | US | disclosed |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2026-02-17 | — | — | US | disclosed |
| US-12465633-B2 | Lipopeptide building blocks and synthetic virus-like particles | VIROMETIX AG (CH) | 2025-11-11 | — | — | US | disclosed |
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Universität Zürich (CH) | 2024-08-29 | — | — | US | disclosed |
| CN-110891592-B | Cyclic peptides for protection against respiratory syncytial virus | 维罗米蒂克斯股份公司 | 2024-08-13 | — | — | CN | disclosed |
| US-RE32455-E | A-21978 antibiotics and process for their production | ELI LILLY AND COMPANY (US) | 1987-07-07 | — | — | US | disclosed |
| US-RE32333-E | BACTERICIDES | ELI LILLY AND COMPANY (US) | 1987-01-20 | — | — | US | disclosed |
| US-RE31396-E | A-21978 Antibiotics and process for their production | ELI LILLY AND COMPANY (US) | 1983-09-27 | — | — | US | disclosed |
| US-4331594-A | PEPTIDE ANTIBIOTICS | ELI LILLY AND COMPANY (US) | 1982-05-25 | — | — | US | disclosed |
| US-4208403-A | A-21978 Antibiotics and process for their production | ELI LILLY AND COMPANY (US) | 1980-06-17 | — | — | US | disclosed |
| EP-0010421-A1 | Mixture of antibiotics designated by A-21978, process for its production, their pharmaceutical compositions and producing microorganism | ELI LILLY AND COMPANY (US) | 1980-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIP, LNPEP, CSTB | SLC7A5 2179/4885SLC1A3 4201/4885SLC1A2 4780/4885 |
| US-20260137767-A1 | LIPOPEPTIDE BUILDING BLOCKS AND SYNTHETIC VIRUS-LIKE PARTICLES | VSIR, LRBA, CD74 | SLC7A5 2164/4885SLC1A3 4257/4885SLC1A2 4754/4885 |
| US-12465633-B2 | Lipopeptide building blocks and synthetic virus-like particles | VSIR, CXCL10, SGTA | SLC7A5 2069/4885SLC1A3 4134/4885SLC1A2 4575/4885 |
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIP, QPCT, QPCTL | SLC7A5 196/4885SLC1A3 685/4885SLC1A2 2572/4885 |
| US-20210101941-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | QPCT, QPCTL, VIP | SLC7A5 277/4885SLC1A3 718/4885SLC1A2 2557/4885 |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | CTH, VIP, CXCL10 | SLC7A5 37/4885SLC1A3 404/4885SLC1A2 1464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.